Anti-GP142/ GPR142/ GPRg1b monoclonal antibody

Anti-GP142/ GPR142/ GPRg1b antibody for FACS & in-vivo assay

Target products collectionGo to GPR142/GPR142 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0509-Ab-1/ GM-Tg-hg-MP0509-Ab-2Anti-Human GPR142 monoclonal antibodyHuman
GM-Tg-rg-MP0509-Ab-1/ GM-Tg-rg-MP0509-Ab-2Anti-Rat GPR142 monoclonal antibodyRat
GM-Tg-mg-MP0509-Ab-1/ GM-Tg-mg-MP0509-Ab-2Anti-Mouse GPR142 monoclonal antibodyMouse
GM-Tg-cynog-MP0509-Ab-1/ GM-Tg-cynog-MP0509-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR142 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0509-Ab-1/ GM-Tg-felg-MP0509-Ab-2Anti-Feline GPR142 monoclonal antibodyFeline
GM-Tg-cang-MP0509-Ab-1/ GM-Tg-cang-MP0509-Ab-2Anti-Canine GPR142 monoclonal antibodyCanine
GM-Tg-bovg-MP0509-Ab-1/ GM-Tg-bovg-MP0509-Ab-2Anti-Bovine GPR142 monoclonal antibodyBovine
GM-Tg-equg-MP0509-Ab-1/ GM-Tg-equg-MP0509-Ab-2Anti-Equine GPR142 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0509-Ab-1/ GM-Tg-hg-MP0509-Ab-2; GM-Tg-rg-MP0509-Ab-1/ GM-Tg-rg-MP0509-Ab-2;
GM-Tg-mg-MP0509-Ab-1/ GM-Tg-mg-MP0509-Ab-2; GM-Tg-cynog-MP0509-Ab-1/ GM-Tg-cynog-MP0509-Ab-2;
GM-Tg-felg-MP0509-Ab-1/ GM-Tg-felg-MP0509-Ab-2; GM-Tg-cang-MP0509-Ab-1/ GM-Tg-cang-MP0509-Ab-2;
GM-Tg-bovg-MP0509-Ab-1/ GM-Tg-bovg-MP0509-Ab-2; GM-Tg-equg-MP0509-Ab-1/ GM-Tg-equg-MP0509-Ab-2
Products NameAnti-GPR142 monoclonal antibody
Formatmab
Target NameGPR142
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GPR142 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GP142/ GPR142/ GPRg1b VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAAV000348human GPR142 AAV plasmid
    ORF Viral VectorvGMAAV000348human GPR142 AAV particle


    Target information

    Target IDGM-MP0509
    Target NameGPR142
    Gene ID350383,217302,501735,100427619,483287,101088197,538511,100060761
    Gene Symbol and SynonymsGPR142,GPRg1b,PGR2,RGD1559926
    Uniprot AccessionQ7Z601
    Uniprot Entry NameGP142_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000257008
    Target ClassificationGPCR

    The target: GPR142, gene name: GPR142, also named as GPRg1b, PGR2. GPR142 is a member of the rhodopsin family of G protein-coupled receptors (GPRs) (Fredriksson et al., 2003 [PubMed 14623098]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.